Peripheral Blood Lymphocyte/Monocyte Ratio Predicts Outcome in Follicular Lymphoma and in Diffuse Large B-Cell Lymphoma Patients in the Rituximab Era-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Peripheral Blood Lymphocyte/Monocyte Ratio Predicts Outcome in Follicular Lymphoma and in Diffuse Large B-Cell Lymphoma Patients in the Rituximab Era

Published:2015-04 Issue:4 Volume:15 Page:208-213
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Belotti Angelo,Doni Elisa,Bolis Silvia,Rossini Fausto,Casaroli Ivana,Pezzatti Sara,Pogliani Enrico Maria,Pioltelli Pietro Enrico

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference41 articles.

1. SEER Cancer Statistics Review;National Cancer Institute,2008

2. Epidemiology of the non-Hodgkin lymphomas: distribution of the major subtypes differ by geographic locations. Non-Hodgkin Lymphoma Classification Project;Anderson;Ann Oncol,1998

3. New developments in the management of diffuse large B-cell lymphoma;Habermann;Hematology,2012

4. A predictive model for aggressive NHL: the International non-Hodgkin Lymphoma Prognostic Factors Project;N Engl J Med,2010

5. The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma;Rosenwald;N Engl J Med,2002

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic model for relapsed/refractory transplant-ineligible diffuse large B-cell lymphoma utilizing the lymphocyte-to-monocyte ratio;International Journal of Hematology;2024-03-16

2. Prognostic value of the peripheral blood lymphocyte/monocyte ratio combined with 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma;Current Problems in Cancer;2024-02

3. Development of a new risk scoring system based on spleen involvement and the lymphocyte/monocyte ratio for follicular lymphoma patients;Leukemia Research;2022-12

4. Clinical and biological prognostic factors in follicular lymphoma patients;PLOS ONE;2022-08-04

5. Low lymphocyte‐to‐monocyte ratio predicts poor outcome in high‐risk aggressive large B‐cell lymphoma;eJHaem;2022-06-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3